Plain-English translation of NCT05722002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing two different approaches to managing pain after surgery. You would receive either NSAIDs (non-steroidal anti-inflammatory drugs) plus , or low-dose opioids plus . Researchers believe the -based approach may work just as well or better while causing fewer side effects than opioids.
After surgery, pain medications are commonly prescribed, but they carry risks of addiction, side effects, and dependency. This trial is testing whether other pain-relief options might be just as effective or even better, while being safer for patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to receive either an -based or -based pain medication regimen after your surgery. Your surgical team will help manage your pain during recovery using the approach assigned to you. You'll track how well the medication works and any side effects you experience so researchers can compare which approach is most effective and safe.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
United States